ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial

June 17, 1994